Taiwan liposaomal Companies
Dr. Hong joined the Liposome Research Laboratory (LRL) as a research scientist at the Cancer Research Institute of University of California, San Francisco for twenty years. After serving as a consultant to several biotechnology companies including Nycomed, Salutar, Onyx, and Sequus, he founded Taiwan Liposome Company (TLC) in Taiwan in 1997 and co-founded Hermes Biosciences in the United States in 1998. Dr. Hong has pioneered the study of the structure and function of biomembranes. With his long time devotion to the advancement of cancer therapy he has achieved a series of breakthroughs in drug carrier technology for improving drug and gene delivery and is an inventor on a number of patents. Dr. Hong received his B.S. in chemistry from Taiwan Cheng Kung University and M.S. in chemistry from the University of Texas at El Paso. He then earned a Ph.D. in Chemistry at the University of California at Berkeley and conducted postdoctoral research at Stanford University.
operation and management of modern Chinese medicine enterprises